TickerGuard
Buy Day today: Poor (52) Mixed market breadth · today: Core PCE (August) ≈
FLNA

Filana Therapeutics, Inc.

Healthcare · Biotechnology

0.7728$ -11.2% vs. previous close Closing price · As of: Sep 24, 2026

Statements

Cash Flow

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Cash Flow FLNA
Line item 2022 2023 2024 2025
– – – –
– +17.6% -26.0% -17.3%
– +122.0% +255.2% +20.2%
– – -120.1% –
– -84.7% -75.1% +464.1%
– – – –
– -94.6% +4,762.1% -100.2%
– – – -544.6%
– – – –

Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?